West Lafayette, IN, United States of America

Endocyte, Inc.


USPTO Granted Patents = 60

% Expired Patents = 53.3



Trademarks = 2

Forward Citations = 795

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Christopher Paul Leamon (54 out of 57 patents)

silverMedal Iontcho Radoslavov Vlahov (39 out of 40 patents)

bronzeMedal Philip Stewart Low (16 out of 111 patents)

4.  Hari Krishna R Santhapuram (12 out of 12 patents)

5.  Paul Joseph Kleindl (9 out of 9 patents)

6.  Joseph Anand Reddy (8 out of 8 patents)

7.  Kevin Yu Wang (8 out of 8 patents)

8.  Fei You (7 out of 7 patents)

9.  Yingjuan June Lu (7 out of 9 patents)

10.  Matthew A Parker (7 out of 7 patents)

11.  Stephen J Howard (6 out of 43 patents)

12.  Apparao Satyam (6 out of 11 patents)

13.  Haiyan Chu (6 out of 7 patents)

14.  Marilynn Vetzel (4 out of 4 patents)

15.  Melissa Nelson (4 out of 4 patents)


Core Competencies:
CAR T Cells
PSMA Conjugates
Imaging Agents
Folate Receptor
Tumor Treatment
Drug Delivery
Conjugates
Vitamin Receptor
Multi-Drug Ligands
Tubulysins
Hydrophilic Spacer Linkers
Combination Therapies

60 patents:

Endocyte, Inc., based in West Lafayette, Indiana, specializes in innovative cancer therapies, focusing on targeted drug delivery systems. The company is known for its development of CAR T cell therapies and PSMA conjugates, which aim to enhance the precision of tumor treatment. Additionally, Endocyte is engaged in creating imaging agents and exploring the therapeutic potential of folate receptors and vitamin receptors, contributing to advancements in oncology and personalized medicine.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Endocyte, Inc.
60 Patents

#5 in West Lafayette, IN

#103 in Indiana

#5,991 in US

#12,077 in the World

West Lafayette, IN (US)
West Lafayette, IN, United States of America
Forward Citations = 795

50 inventors:

Please report any incorrect information to [email protected]
Loading…